[Thrombosis and antithrombotic therapy in the elderly]

Med Clin (Barc). 2011 Oct 15;137(10):468-71. doi: 10.1016/j.medcli.2011.05.004. Epub 2011 Jul 12.

[Article in Spanish]

Authors

José Antonio Páramo¹, Sara Varea, Ramón Lecumberri

Affiliation

¹ Servicio de Hematología, Clínica Universidad de Navarra, Pamplona, Navarra, Spain.

PMID: 21752408
DOI: 10.1016/j.medcli.2011.05.004

No abstract available

Publication types

Review

MeSH terms

Age Distribution
Aged
Aged, 80 and over
Anticoagulants / therapeutic use
Arterial Occlusive Diseases / drug therapy
Arterial Occlusive Diseases / etiology
Atherosclerosis / complications
Atrial Fibrillation / complications
Comorbidity
Embolism / etiology
Embolism / prevention & control
Female
Fibrinolytic Agents / administration & dosage
Fibrinolytic Agents / adverse effects
Fibrinolytic Agents / therapeutic use*
Humans
Male
Medication Adherence
Multicenter Studies as Topic / statistics & numerical data
Polypharmacy
Randomized Controlled Trials as Topic / statistics & numerical data
Thrombolytic Therapy* / adverse effects
Thrombophilia / drug therapy
Thrombophilia / epidemiology
Thrombosis / drug therapy*
Thrombosis / epidemiology
Thrombosis / physiopathology
Venous Thromboembolism / drug therapy
Venous Thromboembolism / epidemiology

Substances

Anticoagulants
Fibrinolytic Agents